JTJocelyn S. Thompson

Jocelyn S. Thompson

*This is an algorithmically generated author record based on publicly available information.

Jocelyn S. Thompson has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinician Perspectives on Educate, Nurture, Advise, Before Life Ends Left Ventricular Assist Device (ENABLE-LVAD) Program

    by Elise Tsai, Jocelyn S. Thompson, Caroline Tietbohl, Daniel D. Matlock, Larry A. Allen, Avery Bechthold, J. Nicholas Odom, Marie A. Bakitas, Colleen K. McIlvennan

    Background: Family caregivers of patients with left ventricular assist devices (LVADs) experience substantial and unique caregiving demands. Clinicians involved in LVAD care frequently interface with caregivers and are uniquely positioned to provide support. The Educate, Nurture, Advise, Before Life Ends Left Ventricular Assist Device (ENABLE-LVAD) program is an adapted, evidence-based palliative care intervention designed to support caregivers through clinician training and caregiver-facing educational materials. Objective: To understand clinician use, experiences, and perspectives on the ENABLE-LVAD program. Methods: From August 2022 to June 2023, LVAD clinicians who voluntarily registered for ENABLE-LVAD training were invited to participate in semi-structured, audio-recorded interviews. Transcripts were analyzed using content analysis to characterize training completion, program use, and clinician perceptions of feasibility and implementation. Results: Among 20 interviewed clinicians, 80% completed at least part of the clinician training. Of these clinicians, 50% used all or part of the ENABLE-LVAD program in practice. Clinicians found the asynchronous, modular format accessible, reported learning new information, and agreed the content was well tailored to the LVAD population. Four broad themes emerged: (1) ENABLE-LVAD clinician training was feasible and useful; (2) ENABLE-LVAD program was flexible and adaptable to clinical contexts; (3) ENABLE-LVAD program timing and delivery should be individualized; (4) ENABLE-LVAD program implementation must account for clinical time constraints. Conclusions: The ENABLE-LVAD program addresses a critical gap in clinician training and caregiver support. Flexible, pragmatic interventions that account for time constraints and existing workflows may enhance caregiver support and inform future program adaptations and randomized trials.

  • iDECIDE-VAD-PEDIATRIC: Development of a Decision Aid to Assist Children and Their Caregivers When Considering a Ventricular Assist Device

    by Seth A. Hollander, Jenna M. Murray, John C. Dykes, Toni Duganiero, Jocelyn S. Thompson, Tiffany Hunter, Kari Christ, Sabena F. Hussain, Daniel D. Matlock, Larry A. Allen, et al.


  • Assessment of caregiver burden prior to implantation of left ventricular assist device: A national survey

    by Andrew S. Baird, Jocelyn S. Thompson, Monica D. Fitzgerald, Bridget S. Mosley, Daniel D. Matlock, Larry A. Allen, Colleen K. Mcllvennan


  • Open Access

    Patient control preferences for medical decision making before and after evaluation for left ventricular assist device

    by Vishal Krishnan, Kaitlyn B. Bertin, Colleen K. McIlvennan, Jocelyn S. Thompson, Daniel D. Matlock, Larry A. Allen


  • “Would You Get a Destination Therapy Left Ventricular Assist Device?”: Health Care Workers’ Views on a Preference-Sensitive Decision

    by Julia E. Haynes, Dan D. Matlock, Jocelyn S. Thompson, Bridget S. Mosley, Monica D. Fitzgerald, Colleen K. McIlvennan, Larry A. Allen


  • “Would You Get A Destination Therapy Left Ventricular Assist Device?”: Health Care Providers Describe A Preference-sensitive Decision

    by Julia Haynes, Daniel Matlock, Jocelyn Thompson, Bridget Mosley, Monica Fitzgerald, Colleen McIlvennan, Larry Allen

  • Stress and Coping Among Family Caregivers of Patients With a Destination Therapy Left Ventricular Assist Device: A Multicenter Mixed Methods Study

    by Colleen K. McIlvennan, Jacqueline Jones, Marybeth Makic, Paula M. Meek, Erin Chaussee, Jocelyn S. Thompson, Daniel D. Matlock, Larry A. Allen

    Background: Family caregivers of patients with a destination therapy left ventricular assist device play a central and formalized role in postimplant care. We aimed to characterize longitudinal stress, predictors and correlates of stress, and coping processes among left ventricular assist device caregivers. Methods: We performed a sequential, exploratory, mixed-methods study from 6 diverse left ventricular assist device programs. The primary outcome for the quantitative analysis was the Perceived Stress Scale-10 at 6 months (0–40). Based on the quantitative findings and guided by the Transactional Model of Stress and Coping, semistructured interviews explored causes of stress and coping processes. Integration was performed during the qualitative and interpretation phase. Results: A total of 96 caregivers met inclusion criteria for quantitative analysis. Mean (SD) Perceived Stress Scale score was 14.3 (5.5) preimplant and 11.8 (6.9) at 6 months. Preimplant, only decreased preparedness for caregiving was associated with higher Perceived Stress Scale score at 6 months. At 6 months, increased caregiver depressive symptoms, decreased caregiver preparedness for caregiving, and lower patient quality of life were associated with higher Perceived Stress Scale score. Qualitative analysis of 25 caregivers revealed the causes of stress coalesced around 3 themes: (1) lack of preparedness to be a caregiver, (2) uniqueness of stress for the caregiver and patient situation, and (3) caregiving responsibilities physically and emotionally impacting caregivers. To cope with stress, most caregivers employed emotion-focused coping. Conclusions: In family caregivers of patients with a left ventricular assist device, higher perceived stress was associated with lower caregiver preparedness, higher caregiver depressive symptoms, and lower patient quality of life. Emotion-focused coping strategies were common for caregivers. Future work should better prepare caregivers for this role and support them through the caregiving experience. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02344576.


  • Open Access

    Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial

    by Christopher E. Knoepke, Erin L. Chaussee, Daniel D. Matlock, Jocelyn S. Thompson, Colleen K. McIlvennan, Amrut V. Ambardekar, Elisabeth M. Schaffer, Prateeti Khazanie, Laura Scherer, Robert M. Arnold, et al.

    Background: Patient-centered care includes matching treatments to patient values and preferences. This assumes clarity and consistency of values and preferences relevant to major medical decisions. We sought to describe stability of patient-reported values regarding aggressiveness of care and preferences for left ventricular assist devices (LVADs) for advanced heart failure. Methods and Results: We conducted a secondary analysis of patients undergoing LVAD evaluation at 6 US centers. Surveys at baseline, 1 month, and 6 months included a single 10-point scale on the value of aggressive care (score 1 = “do everything,” 10 = “live with whatever time I have left”) and treatment preference (LVAD, unsure, no LVAD). Data were captured for 232 patients, of whom 196 were ultimately deemed medically eligible for LVAD, and 161 were surgically implanted by 1 month. Values at baseline favored aggressive care (mean [SD], 2.49 [2.63]), trending toward less aggressive over time (1 month, 2.63 [2.05]; 6 months, 3.22 [2.70]). Between baseline and 1 month, values scores changed by ≥2 points in 28% (50/176), as did treatment preferences for 18% (29/161) of patients. Values score changes over time were associated with lower illness acceptance, depression, and eventual LVAD ineligibility. Treatment preference change was associated with values score change. Conclusion: Most patients considering LVAD were stable in their values and treatment preferences. This stability, as well as the association between unstable treatment preferences and changes to stated values, highlighted the clinical utility of the values scale of aggressiveness. However, a substantial minority reported significant changes over time that may complicate the process of shared decision making. Improved methods to elicit and clarify values, including support to those with depression and low illness acceptance, is critical for patient-centered care. [Box: see text]


  • Social Determinants of Health and Rates of Implantation for Patients Considering Destination Therapy Left Ventricular Assist Device

    by Kelsey Flint, Erin L. Chaussee, Kamal Henderson, Khadijah Breathett, Prateeti Khazanie, Jocelyn S. Thompson, Colleen K. McIlvennan, Shane J. Larue, Daniel D. Matlock, Larry A. Allen


  • Shared Decision-Making for Left Ventricular Assist Devices

    by Jocelyn S. Thompson, Monica D. Fitzgerald, Larry A. Allen, Colleen K. McIlvennan, Russell E. Glasgow, Matthew Wynia, Megan A. Morris, John Beilenson, Chris Gherst, Dan D. Matlock

    Background: The left ventricular assist device (LVAD) has become a common medical option for patients with end-stage heart failure. Although patients’ chances of survival may increase with an LVAD compared with medical therapy, the LVAD poses many risks and requires major lifestyle changes, thus making it a complex medical decision. Our prior work found that a decision aid for LVADs significantly increased decision quality for both patients and caregivers and was successfully implemented at 6 LVAD programs. Methods: In follow-up, we are conducting a nationwide dissemination and implementation project, with the goal of implementing the decision aid at as many of the 176 LVAD programs in the United States as possible. Guided by the Theory of Diffusion of Innovations, the project consists of 4 phases: (1) building a network; (2) promoting adoption; (3) supporting implementation; and (4) encouraging maintenance. Developing an LVAD network of contacts occurs by using a national baseline survey of LVAD clinicians, existing professional relationships, and an internet-based strategy. A suite of resources targeted to promote adoption and support implementation of the decision aid into standard LVAD education processes are provided to the network. Evaluation is guided by the Reach, Effectiveness, Adoption, Implementation, Maintenance framework, where clinician and patient surveys and qualitative interviews determine the reach, effectiveness, adoption, implementation, and maintenance achieved. Conclusions: This project is a true dissemination study in that it targets the entire population of LVAD programs in the United States and is unique in its use of social marketing principles to promote adoption and implementation. The implementation plan is intended to serve as a test case and model for dissemination and implementation of other evidence-based decision support aids and strategies.